Table 3.
Distribution of signs and symptoms indicating peripheral nervous system involvement in patients with COVID-19
| Signs and symptoms indicating peripheral nervous system involvement | No. of patients / Proportion |
|---|---|
| Smell/taste impairment | 746 (52·8%) |
| Anosmia and ageusia | 477 |
| Anosmia/hyposmia | 128 |
| Ageusia/dysgeusia | 141 |
| Visual impairment | 9 (0·6%) |
| Unspecified decreased visual acuity | 8 |
| Complete visual loss | 1 |
| Oculomotor impairment | 14 (1%) |
| Ophthalmoparesis | 7 |
| Diplopia | 3 |
| Anisocoria | 1 |
| Bilateral mydriasis | 1 |
| Bilateral abducens palsy | 1 |
| Unilateral abducens palsy | 1 |
| Facial palsy | 13 (0·9%) |
| Bilateral weakness/diplegia | 7 |
| Unilateral | 6 |
| Other cranial nerve impairment | 32 (2·3%) |
| Glossopharyngeal neuralgia | 9 |
| Trigeminal neuralgia | 8 |
| Tinnitus | 5 |
| Decreased hearing | 5 |
| Vasoglossopharyngeal neuralgia | 2 |
| Dysphagia | 2 |
| Reduced tongue movements/tongue deviation | 1 |
| Peripheral neuropathies involving trunk and limbs | 353 (24·9%) |
| Mixed neuropathy | 247 |
| Pure sensitive impairment | 31 |
| Paresthesia | 30 |
| Hypoesthesia | 1 |
| Pure motor impairment | 40 |
| Areflexia | 14 |
| Distal weakness | 8 |
| Tetraparesis | 7 |
| Gait difficulties/instability | 6 |
| Paraparesis | 3 |
| Tetraplegia | 1 |
| Paraplegia | 1 |
| Neuralgia | 8 |
| Limb neuralgia | 7 |
| Occipital neuralgia | 1 |
| Dysautonomia manifestations | 27 |
| Nerve roots and plexus disorders | 145 (10·3%) |
| Myopathic involvement | 102 (7·2%) |
| Total patients with PNS signs and symptoms | 1414 (100%) |